# OnCo record nct03784014 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct03784014/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct03784014", "NCT03784014" ;
  schema:name "Molecular Profiling of Advanced Soft-tissue Sarcomas"@en ;
  schema:description "A phase 3 trial of Nilotinib, Ceritinib, Capmatinib, Lapatinib, Trametinib, Olaparib, Palbociclib and Glasdegib in Sarcomas, run by Institut National de la Santé Et de la Recherche Médicale, France, completed."@en ;
  schema:url <https://onco.cc/trials/nct03784014/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT03784014> ;
  onco:status "completed" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "3" ;
  onco:cancers <https://onco.cc/cancers/sarcoma/> ;
  onco:drugs <https://onco.cc/drugs/nilotinib/>, <https://onco.cc/drugs/ceritinib/>, <https://onco.cc/drugs/capmatinib/>, <https://onco.cc/drugs/lapatinib/>, <https://onco.cc/drugs/trametinib/>, <https://onco.cc/drugs/olaparib/>, <https://onco.cc/drugs/palbociclib/>, <https://onco.cc/drugs/glasdegib/> .